<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201211049678N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-07-29</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Exercise and nutrition effect on Autism</public_title>
      <acronym></acronym>
      <scientific_title>Effect of Functional Exercise Along with online Nutritional Education on Inflammatory-Oxidative and Metabolic Profile in Children with Autism Spectrum Disorder during Covid-19 Pandemic</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/57068</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: This study is a clinical trial with pre-test and post-test and participants will be children diagnosed with autism spectrum disorder approved by neurologist. Targeted sampling with available participants will be recruited for participants selection. Among 100 eligible individuals, 80 participants will be selected according to Morgan chart. Then, participants will randomly receive specific codes by using random allocation software, without researches awareness. Participants will be divided into 4 groups according to their random codes as following: 1) functional exercise, 2) online nutritional education, 3) functional exercise+ online nutritional education and 4) control group. Participants with codes 1-20 will be allocated in functional exercise group, participants who received codes 21-40 will be allocated in online nutritional education group and allocation for functional exercise+ online nutritional education and control group will be for codes 41-60 and 61-80 respectively. In order to prevent from any bias, all sampling process, participants selection, specific codes allocation and participants grouping will be without researcher awareness. Moreover, the intervention process will be done under occupational therapist, physiotherapist and nutritionist super vision and via their assistance, Blinding description: Each candidate will randomly receive specific codes using random allocation software without researcher involvement or awareness. Participants will be allocated in one of the for groups according to their codes. All the sampling, randomized code allocation and grouping, will be recruited without researcher awareness and with occupational therapist, physiotherapist and nutritionist supervision and assistance.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Autism Spectrum Disorder.</hc_freetext>
      <i_freetext>Intervention 1: Functional group, will participate in 8 weeks functional training including warm up, going up and down the stairs, sit-to-stand using weight and cool down at the end of the sessions for 3 times per week for 60 minutes each session. Intervention 2: Online nutritional education group will participate in online nutritional education sessions for 3 time per week and 30 minutes in each session. Intervention 3: Functional exercise and online nutritional education group will participate in exercise and online education session for 8 weeks, 3 session per week for 90 minutes. Intervention 4: Control group will not receive any exercise or online nutritional education intervention and only will participate in pre-test and post-test.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data from variables and their outcomes will be available after Unidentifiabling

When:
6 month after results publication

To whom:
Researchers

Conditions:
Researchers can use study design and its results for future studies

Where to obtain:
Researcher

How to obtain:
Researchers can contact for future information for future studies after results publication via kimia.moiniafshari@srbiau.ac.ir

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mandana Gholami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Science and Research Branch, Daneshgah Blvd, Simon Bulivar Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۷۷۸۹۳۸۵۵</zip>
        <telephone>+98 21 4486 5179</telephone>
        <email>gholami_man@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mandana Gholami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Science and Research Branch, Daneshgah Blvd, Simon Bulivar Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1477893855</zip>
        <telephone>+98 21 4486 5179</telephone>
        <email>gholami_man@yahoo.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Autism spectrum disorder diagnosis approved by neurologist
No inhibition for physical activity
No experience of physical activity within past 6 month
Not reaching maturity according to specialist diagnosis</inclusion_criteria>
      <agemin>8 years</agemin>
      <agemax>12 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Reaching to puberty according to specialist approval
Any prohibition from physical activity
Any medical conditions or disease which inhibits physical activity</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Functional group, will participate in 8 weeks functional training including warm up, going up and down the stairs, sit-to-stand using weight and cool down at the end of the sessions for 3 times per week for 60 minutes each session.</i_keyword>
      <i_keyword>Online nutritional education group will participate in online nutritional education sessions for 3 time per week and 30 minutes in each session.</i_keyword>
      <i_keyword>Functional exercise and online nutritional education group will participate in exercise and online education session for 8 weeks, 3 session per week for 90 minutes.</i_keyword>
      <i_keyword>Control group will not receive any exercise or online nutritional education intervention and only will participate in pre-test and post-test</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Lower limb strength. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Sits to stand test.</prim_outcome>
      <prim_outcome>Upper limb strength. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 1 kilogram dumbbell press.</prim_outcome>
      <prim_outcome>Abdominal strength. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Push ups test.</prim_outcome>
      <prim_outcome>Flexibility. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Modified sit and reach test.</prim_outcome>
      <prim_outcome>Cardio-respiratory endurance. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 6 minutes walking test.</prim_outcome>
      <prim_outcome>Lipid profile. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</prim_outcome>
      <prim_outcome>Insulin resistance indicator. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</prim_outcome>
      <prim_outcome>Waist to hip circumference ratio (WHR). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Waist and hip circumference measurement and division to each other.</prim_outcome>
      <prim_outcome>Fat mass. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Caliper.</prim_outcome>
      <prim_outcome>C-reactive protein (CRP). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</prim_outcome>
      <prim_outcome>White blood cells (WBC). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</prim_outcome>
      <prim_outcome>Superoxide dismutase enzyme (SOD). Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</prim_outcome>
      <prim_outcome>Lactate dehydrogenase enzyme. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital veil blood sample.</prim_outcome>
      <prim_outcome>Glutathione peroxidase enzyme. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</prim_outcome>
      <prim_outcome>Catalase enzyme. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</prim_outcome>
      <prim_outcome>Speed. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 10 minutes walking test.</prim_outcome>
      <prim_outcome>Balance. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Flamingo and Time-Up-and-GO tests.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Lower limb muscle strenght. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Sit-to-stand test.</sec_outcome>
      <sec_outcome>Upper limb muscle strenght. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 1 kilogram dumbbell press.</sec_outcome>
      <sec_outcome>Abdominal muscle strenght. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Push-ups test.</sec_outcome>
      <sec_outcome>Flexibility. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Modified sit-and-reach test.</sec_outcome>
      <sec_outcome>Cardio-respiratory endurance. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 6 minutes walking test.</sec_outcome>
      <sec_outcome>Lipid profile indicators. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</sec_outcome>
      <sec_outcome>Insulin resistance indicator. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</sec_outcome>
      <sec_outcome>Waist-to-hip ratio. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Waist and hip circumference measurement and division to each other.</sec_outcome>
      <sec_outcome>Fat mass. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Caliper.</sec_outcome>
      <sec_outcome>C-reactive protein. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</sec_outcome>
      <sec_outcome>White blood cells. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</sec_outcome>
      <sec_outcome>Superoxide dismutase enzyme. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</sec_outcome>
      <sec_outcome>Lactate dehydrogenase enzyme. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</sec_outcome>
      <sec_outcome>Gluthatione peroxidase enzyme. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital vein blood sample.</sec_outcome>
      <sec_outcome>Catalase enzyme. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Anterior cubital blood vein sample.</sec_outcome>
      <sec_outcome>Speed. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: 10 minutes walking test.</sec_outcome>
      <sec_outcome>Balance. Timepoint: Before the study as pre-test and at the end of 8 weeks intervention as post-test. Method of measurement: Flamingo and Time-Up-and-Go (TUGT) test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University Science And Research Branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-06-16</approval_date>
        <contact_name>Islamic Azad university- science and research branch</contact_name>
        <contact_address>13th floor, Block A, ministry of health and medical education head quarter, Simaye Iran street, between South Falamak and Zarafshan street, Shahrake-e-Gharb, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
